RecruitingNot Applicable

Clinical Outcome in Patients With INPH

China200 participantsStarted 2024-05-15

Plain-language summary

The aim of this study is to determine the clinical spectrum and natural progression of idiopathic normal pressure hydrocephalus （iNPH ) and related disorders in a prospective single center study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the etiology and molecular mechanisms of these diseases.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who was diagnosed as idiopathic normal pressure hydrocephalus Exclusion Criteria: * patient received surgical treatment or interventional treatment before patient is pregnant patient unable to complete follow-up patient with other types of hydrocephalus other nervous system diseases

What they're measuring

DTIALPS

Timeframe: Change from Baseline at 6 months after VP shunt

Trial details

NCT IDNCT06428734

SponsorXuanwu Hospital, Beijing

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-15

Contact for this trial

fengzeng jian, md

01083198899 jianfengzeng@xwh.ccmu.edu.cn

View on ClinicalTrials.gov More Hydrocephalus trials